SCHEMBL6705495

SCHEMBL6705495

COCCOc1cc2cnc(N3CCNCC3)nc2cc1OCCOC

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 13/20 0.51
CYP1A2 P05177 12/20 0.51
CASP1 P29466 11/20 0.51
CASP7 P55210 11/20 0.51
HSD17B10 Q99714 11/20 0.51
HPGD P15428 9/20 0.51
CHRNB2 P17787 1/20 0.46
CHRNA4 P43681 1/20 0.46
KDM4E B2RXH2 1/20 0.45
APAF1 O14727 1/20 0.45
POLB P06746 1/20 0.45
MAPT P10636 1/20 0.45
UBE2N P61088 1/20 0.45
CYP3A4 P08684 9/20 0.45
CYP2C9 P11712 8/20 0.45
HIF1A Q16665 7/20 0.45
USP2 O75604 5/20 0.45
GLA P06280 2/20 0.45
TSHR P16473 4/20 0.42
ALOX15 P16050 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2920903 0.86 CHRNB2 (0.46) ALDH1A1CYP1A2CASP1CASP7HSD17B10
SCHEMBL2921304 0.85 ALDH1A1 (0.60) ALDH1A1CYP1A2CASP1CASP7HSD17B10
SCHEMBL3368105 0.83 CHRNB2 (0.52) ALDH1A1CYP1A2CASP1CASP7HSD17B10
SCHEMBL3366838 0.83 CHRNB2 (0.52) ALDH1A1CYP1A2CASP1CASP7HSD17B10
SCHEMBL2921147 0.81 ALDH1A1 (0.55) ALDH1A1CYP1A2CASP1CASP7HSD17B10
SCHEMBL1132491 0.78 ALDH1A1 (0.43) ALDH1A1CYP1A2CASP1CASP7HSD17B10
SCHEMBL31398803 0.76 CHRNB2 (0.56) ALDH1A1CYP1A2CASP1CASP7HSD17B10
SCHEMBL29478525 0.74 MAPT (0.47) ALDH1A1CASP1KDM4EMAPTUSP2
SCHEMBL6705489 0.72 KDM1A (0.76) ALDH1A1CYP1A2CYP3A4USP2PDGFRB
SCHEMBL29922379 0.71 KIT (0.41) PDGFRBKITPDGFRAPDPK1TLR9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040259881-A1 Nitrogenous heterocyclic compounds KYOWA HAKKO KOGYO CO, LTD. (JP) 2004-12-23 US disclosed
EP-1309567-A2 NITROGENOUS HETEROCYCLIC COMPOUNDS Millennium Pharmaceuticals, Inc. (US) 2003-05-14 EP disclosed
WO-2002016360-A2 NITROGENOUS HETEROCYCLIC COMPOUNDS COR THERAPEUTICS, INC. (US) 2002-02-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040259881-A1 Nitrogenous heterocyclic compounds WNK2, CDK5, PDGFRA ALDH1A1 3597/4885CYP1A2 4602/4885CASP1 3762/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.